A 67-Year-Old Man with Chronic Lymphocytic Leukemia

John Allan, MD, reviews the diagnosis and treatment of a 67-year-old man with chronic lymphocytic leukemia while highlighting potential treatment options.

EP. 1: Case Presentation: A 67-Year-Old Man with Chronic Lymphocytic Leukemia

December 17th 2021

John Allan, MD, presents and reviews the case of a 67-year-old man with chronic lymphocytic leukemia.

EP. 2: Testing and Risk Stratification in CLL

December 17th 2021

A key opinion leader shares insight into testing and risk stratification for chronic lymphocytic leukemia.

EP. 3: First-Line Therapy Options in CLL

December 17th 2021

John Allan, MD, highlights treatment options in the first-line setting for chronic lymphocytic leukemia.

EP. 4: Chronic Lymphocytic Leukemia: RESONATE-2 Trial

December 20th 2021

A leukemia specialist details the Resonate-2 clinical trial studying BTK inhibitor ibrutinib.

EP. 5: Comparing BTK Inhibitors in CLL Treatment

December 20th 2021

John Allan, MD, compares the available approved BTK inhibitors for treating chronic lymphocytic leukemia.

EP. 6: Treatment Approaches for High-Risk Chronic Lymphocytic Leukemia

December 20th 2021

An expert describes various treatment approaches for patients with high-risk chronic lymphocytic leukemia.

EP. 7: The Future of Chronic Lymphocytic Leukemia Treatment

December 20th 2021

John Allan, MD, looks to the future of chronic lymphocytic leukemia treatments.